1. The labelling of medicinal products for human use and on package leaflets. Brussels: European Commission Council Directive; 1992.
http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:31992L0027&from=EN
.
2. Raynor DK, Silcock J, Knapp P, Edmondson H. How do patients use medicine information leaflets in the UK? Int J Pharm Pract. 2007;15(3):209–18. doi:
10.1211/ijpp.15.3.0008
.
3. Fagerlin A, Zikmund-Fisher BJ, Ubel PA. Helping patients decide: ten steps to better risk communication. J Natl Cancer Inst. 2011. doi:
10.1093/jnci/djr318
.
4. A guideline on the readability of the label and package leaflet of medicinal products for human use. Brussels: European Commission; 1998.
http://www.pharma-eu.com/pdfs/Guideline%20on%20Readbaility%20EMEA.pdf
.
5. Council for International Organizations of Medical Sciences Working Group 3. Guidelines for preparing core clinical-safety information on drugs: report of CIOMS Working Group III. Geneva: World Health Organisation; 1995. ISBN: 9290360623.